Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Call Transcript
Source: SeekingAlpha
2025-08-03 21:36:32 ET
Ono Pharmaceutical Co., Ltd. (OPHLF)
Q1 FY2025 Earnings Conference Call
August 01, 2025 01:00 AM ET
Company Participants
Hirokazu Kitada - Corporate Participant
Sales and Marketing - Corporate Participant
Hiroyuki Takahashi - Director of Oncology Business Division, Sales and Marketing
Masaki Ito - Corporate Executive Officer & Div. Director of Corporate Strategy & Planning, Bus. Management Div.
Ryuta Imura - Senior Director, Corporate Communications
Tatsuya Okamoto - Corporate Officer & Executive Director, Clinical Development, Oncology Clinical Development Div....
Read the full article on Seeking Alpha
For further details see:
Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Call Transcript
Ono Pharmaceutical Co Ltd ADR
NASDAQ: OPHLY
OPHLY Trading
-0.94% G/L:
$4.9845 Last:
88,072 Volume:
$4.98 Open:
